GO
Loading...

Johnson & Johnson

More

  • Final Glance: Pharmaceuticals companies Monday, 11 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 30 or. 4 percent, to $74.20. Bristol-Myers Squibb Co. fell$. 10 or. 2 percent, to $49.09. Hospira rose$. 19 or. 3 percent, to $54.57.

  • The Ebola epidemic in West Africa has killed nearly 1,000 people and prompted the World Health Organization to declare an international health emergency. GSK is co-developing a vaccine with the U.S. National Institute of Allergy and Infectious Diseases, which has shown promising results in primates.

  • Midday Glance: Medical Devices companies Monday, 11 Aug 2014 | 1:26 PM ET

    Allergan fell $3.20 or 2.0 percent, to $153.63. Baxter International Inc. rose$. 67 or. 9 percent, to $74.57. Boston Scientific Corp. rose$. 03 or. 2 percent, to $12.36.

  • Midday Glance: Pharmaceuticals companies Monday, 11 Aug 2014 | 1:26 PM ET

    Baxter International Inc. rose$. 67 or. 9 percent, to $74.57. Bristol-Myers Squibb Co. rose$. 21 or. 4 percent, to $49.40. Johnson& Johnson rose$. 21 or. 2 percent, to $101.29.

  • Early Glance: Medical Devices companies Monday, 11 Aug 2014 | 10:35 AM ET

    Allergan fell $1.69 or 1.1 percent, to $155.14. Baxter International Inc. rose$. 51 or. 7 percent, to $74.41. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.26.

  • Clinical trial to start soon on GSK Ebola vaccine Sunday, 10 Aug 2014 | 11:33 AM ET

    LONDON, Aug 10- A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with U.S. scientists.

  • LONDON, Aug 6- The U.S. economy continues to recover from the depths of the Great Recession, although its speed, trajectory and cruising altitude remain the subject of fierce debate. Instead, companies have chosen to dip into their collective $1.8 trillion pile of cash to re-hire workers, fund merger and acquisitions activity or buy back their own shares.

  • Highmark Inc, which has customers in Pennsylvania, Delaware and West Virginia, will stop covering the procedure on Sept. 1, company spokesman Aaron Billger said in an email.

  • Aug 1- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc..

  • July 30- Johnson& Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids. The FDA had advised doctors not to use the devices pending further review.

  • The Senate Judiciary Committee's nine-member antitrust panel will meet on Wednesday to consider the decisions by Alcon, owned by Novartis AG; Bausch& Lomb, owned by Valeant Pharmaceuticals; and Johnson& Johnson to put in place minimum sale prices for some of their products.

  • The Senate Judiciary Committee's nine-member antitrust panel will meet on Wednesday to consider the decisions by Alcon, owned by Novartis AG; Bausch+ Lomb, owned by Valeant Pharmaceuticals; and Johnson& Johnson to put in place minimum sale prices for some of their products.

  • Europe backs new leukemia drugs from J&J and Gilead Friday, 25 Jul 2014 | 7:20 AM ET

    LONDON, July 25- Two new leukemia drugs from Johnson& Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months. The European Medicines Agency said on Friday its experts had issued positive opinions for J&J's ibrutinib, developed with Pharmacyclics, and Gilead's idelalisib.

  • Early movers: KO, MCD, VZ, AAPL, NFLX, CS & more Tuesday, 22 Jul 2014 | 8:06 AM ET
    Traders work the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • July 18- Advertising company Interpublic Group of Cos Inc reported better-than-expected quarterly revenue, boosted by strong growth in the UK and higher ad spending in its core U.S. market. Interpublic's clients include General Motors, Unilever and Johnson& Johnson.

  • Stocks end with weekly gains as Ukraine tensions ebb Friday, 18 Jul 2014 | 4:17 PM ET
    A trader works on the floor of the New York Mercantile Exchange.

    Stocks rose Friday, with the S&P 500 rebounding from its largest drop since April 10.

  • July 18- Advertising company Interpublic Group of Cos Inc reported better-than-expected quarterly revenue, boosted by strong growth in the UK and higher ad spending in its core U.S. market. Interpublic's clients include General Motors, Unilever and Johnson& Johnson.

  • July 18- Advertising company Interpublic Group of Cos Inc reported better-than-expected quarterly revenue, boosted by a strengthening international market and higher ad spending in the United States. Interpublic's clients include General Motors, Unilever and Johnson& Johnson.

  • POWRANNA, Australia, July 18- Thousands of Black Angus bulls snort steam gently into the frigid early morning air at Tasmania's largest cattle feedlot as they jostle for space at a long grain trough.

  • Sovaldi—$55 billion headache for states Thursday, 17 Jul 2014 | 10:18 AM ET

    States may be on the hook for $55 billion to pay for hepatitis C treatments like Sovaldi, a new study says.